Improved needle designs could increase patient compliance with insulin therapy. In this issue of Journal of Diabetes Science and Technology, Hirsch and colleagues assessed patient pain and preference for a 5-bevel needle design among diabetes patients. A blinded comparison with traditional 3-bevel needles yielded no significant difference, but patients preferred the 5-bevel needle in unblinded home injection and clinical insertion studies. This suggests that important subjective/contextual factors contribute to preference in conjunction with the fundamental needle design change. While 5-bevel needles may increase patient acceptance, more dramatic changes of needle design, such as microneedles, could enable still greater patient acceptance through reduced pain as well as improved insulin pharmacokinetics.
RubinRRPeyrotMKrugerDFTravisLB. Barriers to insulin injection therapy: Patient and health care provider perspectives. Diabetes Educ.2009; 35 (6): 1014–1022.
2.
VedrineLPraisWLaurentPERaynal-OliveCFantinoM. Improving needle-point sharpness in prefillable syringes. Med Device Technol.2003; 14 (4): 32–5.
3.
HirschLGibneyMBerubeJManocchioJ. The impact of a modified needle tip geometry on penetration force as well as acceptability, preference and perceived pain in subjects with diabetes. J Diabetes Sci Technol.2012; 6 (2): 328–35.
4.
JaberABozzatoGBVedrineLPraisWABerubeJLaurentPE. A novel needle for subcutaneous injection of interferon beta-1a: Effect on pain in volunteers and satisfaction in patients with multiple sclerosis. BMC Neurol.2008; 8: 38.
5.
KugerL. Pain and touch. 1st ed.San Diego: Academic Press; 1996.
ShaughnessyJZechmeisterEZechmeisterJ. Research methods in psychology. 8th ed.New York: McGraw Hill; 2008.
8.
MooreJZMcLaughlinPWShihAJ. Novel needle cutting edge geometry for end-cut biopsy. Med Phys.2012; 39 (1): 99.
9.
DavisSPLandisBJAdamsZHAllenMGPrausnitzMR. Insertion of microneedles into skin: Measurement and prediction of insertion force and needle fracture force. J Biomech.2004; 37 (8): 1153–63.
10.
PrausnitzMRGillHSParkJ-H. Microneedles for drug delivery. In: Modified release drug delivery. 2nd ed.RathboneMJHadgraftJRobertsMSLaneME, eds. New York: Informa Press; 2008.
11.
GillHSDensonDDBurrisBAPrausnitzMR. Effect of microneedle design on pain in human volunteers. Clin J Pain.2008; 24 (7): 585–94.
12.
HaqMISmithEJohnDNKalavalaMEdwardsCAnsteyAMorrisseyABirchallJC. Clinical administration of microneedles: Skin puncture, pain and sensation. Biomed Microdevices.2009; 11 (1): 35–47.
13.
GuptaJFelnerEIPrausnitzMR. Rapid pharmacokinetics of intradermal insulin administered using microneedles in type 1 diabetes subjects. Diabetes Technol Ther.2011; 13 (4): 451–6.
14.
PettisRJHirschLKapitzaCNosekLHövelmannUKurthHJSutterDEHarveyNGHeinemannL. Microneedle-based intradermal versus subcutaneous administration of regular human insulin or insulin lispro: Pharmacokinetics and postprandial glycemic excursions in patients with type 1 diabetes. Diabetes Technol Ther.2011; 13 (4): 443–50.
15.
HarveyAJKaestnerSASutterDEHarveyNGMiksztaJAPettisRJ. Microneedle-based intradermal delivery enables rapid lymphatic uptake and distribution of protein drugs. Pharm Res.2011; 28 (1): 107–16.
